NDC 50090-2301-01 - Mucinex Maximum Strength
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-2301
- Requested NDC
- 50090-2301-01
- Package NDCs from labels
- 50090-2301-0, 50090-2301-1, 50090-2301-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2025-06-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Mucinex Maximum Strength - A-S Medication Solutions | A-S Medication Solutions | 2025-06-09 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50090-2301-0 | 2023-02-06 | C162847 | 48780-1 | f386c649-eea7-0266-e053-dadaa90a7c1a | MUCINEX MAXIMUM STRENGTH |
| 50090-2301-0 | 2023-01-30 | C162847 | 48780-1 | f386c649-eea7-0266-e053-dadaa90a7c1a | MUCINEX MAXIMUM STRENGTH |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-2301-0 | MucinexMaximum Strength | 1 in 1 CARTON | TABLET, EXTENDED RELEASE | 1 | 17 | |
| 50090-2301-0 | MucinexMaximum Strength | 7 in 1 BLISTER PACK | TABLET, EXTENDED RELEASE | 7 | 17 | |
| 50090-2301-1 | MucinexMaximum Strength | 2 in 1 CARTON | TABLET, EXTENDED RELEASE | 2 | 17 | |
| 50090-2301-1 | MucinexMaximum Strength | 7 in 1 BLISTER PACK | TABLET, EXTENDED RELEASE | 7 | 17 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-2301 | MUCINEX MAXIMUM STRENGTH (GUAIFENESIN) TABLET, EXTENDED RELEASE [A-S MEDICATION SOLUTIONS] | 14 | Current NDC, Legacy NDC, 4 package rows | 20231207_7e09314c-3421-4053-a2ac-b67bf5610f83.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-2301-0 | EA - Each | 50090-2301 | c22da608-cd69-4237-961a-e2dd51db5214 | 1 | 2018-11-06 |
| 50090-2301-1 | EA - Each | 50090-2301 | 14b7662d-abc9-4b28-8fad-891706111435 | 1 | 2025-09-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Maximum Strength Cold Flu and Sore Throat | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | KROGER COMPANY | e1d27123-358f-4b0c-8e3b-33474750a0e6 | 2026-09-02 | Warnings | 495W7451VQ |
| Daytime Cold and Flu Relief | ACETAMINOHPEN, DEXTROMETHORPHAN HBR, GUAIFENESIN PHENYLEPHRINE HCL | The Kroger Co. | 494e69ef-dc9f-4e14-b856-5eaf0f541a03 | 2026-09-02 | Warnings | 495W7451VQ |
| Leader Mucus Relief DM | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Cardinal Health 110, LLC. dba Leader | 7c54d128-9da7-49d7-bda4-9d4f7b8bc652 | 2026-09-01 | Warnings | 495W7451VQ |
| MAX Tussin Cough and Chest Congestion DM Sugar Free | DEXTROMETHORPHAN HBR, GUAIFENESIN | Akron Pharma Inc. | 5c4c8115-cec9-4f2c-9ea9-328535e97b07 | 2026-09-01 | Warnings | 495W7451VQ |
| BMNP ALUMINUM OXIDE | ALUMINUM OXIDE | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5a5ad83a-0ecb-21fa-e063-6294a90a1422 | 2026-08-31 | Warnings | LMI26O6933 |
| MAX Tussin Mucus and Chest Congestion Sugar Free | GUAIFENESIN | Akron Pharma Inc. | 3b023b91-e703-4599-9864-96d8c328b45c | 2026-08-31 | Warnings | 495W7451VQ |
| MAX Tussin Mucus and Chest Congestion | GUAIFENESIN | Akron Pharma Inc. | ac874a31-5556-4669-937f-dcb52aaecd8a | 2026-08-31 | Warnings | 495W7451VQ |
| MAX Tussin Cough and Chest Congestion DM | DEXTROMETHORPHAN HBR, GUAIFENESIN | Akron Pharma Inc. | e0ce4287-bfa1-4413-97c8-4fe2e39bda36 | 2026-08-31 | Warnings | 495W7451VQ |
| Mucinex DM | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | Select Consumer Group | 3c9c8fb0-8a00-4b0f-e063-6394a90af632 | 2026-08-30 | Warnings | 495W7451VQ |
| Tussin DM Daytime | DEXTROMETHORPHAN HBR, GUAIFENESIN | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 432d4833-2eaf-4f7c-b6b4-41043a6b7e2a | 2026-08-28 | Warnings | 495W7451VQ |
| Maximum Strength Mucus Relief DM | GUAIFENESIN AND DEXTROMETHORPHAN HBR | Wal-Mart Stores, Inc. | ff7280e7-804b-423d-add8-54ec2c76fca2 | 2026-08-28 | Warnings | 495W7451VQ |
| Mucus Relief DM | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Walgreen Company | d8a693f7-03c1-4583-89a8-8d506a894b24 | 2026-08-28 | Warnings | 495W7451VQ |
| Maximum Strength Mucus Relief | DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Hyvee Inc | 4e578c7a-88d4-e4cd-e063-6394a90aac44 | 2026-08-27 | Warnings | 495W7451VQ |
| MUCUS RELIEF | GUAIFENESIN | Geri-Care Pharmaceuticals, Corp | 5afb242f-fac9-dc81-e063-6394a90a8448 | 2026-08-27 | Warnings | 495W7451VQ |
| Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Meijer Distribution, Inc. | c1f9ec75-7eb2-405c-8cdc-097cbf2cf87d | 2026-08-26 | Warnings | 495W7451VQ |
| robafen dm | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Preferred Pharmaceuticals Inc. | 5b2fd5ce-56ab-491a-81b9-44e35a5d2316 | 2026-08-26 | Warnings | 495W7451VQ |
| mucus dm | DEXTROMETHORPHAN HBR, GUAIFENESIN | HyVee Inc | 6bce66d6-e76a-4273-aff9-7ee6adc18980 | 2026-08-25 | Warnings | 495W7451VQ |
| good neighbor pharmacy mucus dm | DEXTROMETHORPHAN HBR, GUAIFENESIN | Amerisource Bergen | f7925a6b-7029-4389-bf1b-8c0f5e79b950 | 2026-08-25 | Warnings | 495W7451VQ |
| DG health mucus dm | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Dolgencorp Inc | a95401cc-349e-435a-b953-4d8fd1f54744 | 2026-08-24 | Warnings | 495W7451VQ |
| Curist Mucus Relief Maximum Strength | GUAIFENESIN | Little Pharma, Inc. | c7d1136c-a712-2ac5-e053-2995a90a4dd4 | 2026-08-24 | Warnings | 310621 495W7451VQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.